Goñi-Urriza Marisol, Arpin Corinne, Capdepuy Michèle, Dubois Véronique, Caumette Pierre, Quentin Claudine
Laboratoire de Microbiologie, Université de Bordeaux 2, Bordeaux. Laboratoire d'Ecologie Moléculaire, Université de Pau, Pau, France.
Antimicrob Agents Chemother. 2002 Feb;46(2):350-9. doi: 10.1128/AAC.46.2.350-359.2002.
Most Aeromonas strains isolated from two European rivers were previously found to be resistant to nalidixic acid. In order to elucidate the mechanism of this resistance, 20 strains of Aeromonas caviae (n = 10), A. hydrophila (n = 5), and A. sobria (n = 5) complexes, including 3 reference strains and 17 environmental isolates, were investigated. Fragments of the gyrA, gyrB, parC, and parE genes encompassing the quinolone resistance-determining regions (QRDRs) were amplified by PCR and sequenced. Results obtained for the six sensitive strains showed that the GyrA, GyrB, ParC, and ParE QRDR fragments of Aeromonas spp. were highly conserved (> or =96.1% identity), despite some genetic polymorphism; they were most closely related to those of Vibrio spp., Pseudomonas spp., and members of the family Enterobacteriaceae (72.4 to 97.1% homology). All 14 environmental resistant strains carried a point mutation in the GyrA QRDR at codon 83, leading to the substitution Ser-83-->Ile (10 strains) or Ser-83-->Arg. In addition, seven strains harbored a mutation in the ParC QRDR either at position 80 (five strains), generating a Ser-80-->Ile (three strains) or Ser-80-->Arg change, or at position 84, yielding a Glu-84-->Lys modification. No amino acid alterations were discovered in the GyrB and ParE QRDRs. Double gyrA-parC missense mutations were associated with higher levels of quinolone resistance compared with the levels associated with single gyrA mutations. The most resistant strains probably had an additional mechanism(s) of resistance, such as decreased accumulation of the drugs. Our data suggest that, in mesophilic Aeromonas spp., as in other gram-negative bacteria, gyrase and topoisomerase IV are the primary and secondary targets for quinolones, respectively.
先前发现,从两条欧洲河流中分离出的大多数气单胞菌菌株对萘啶酸耐药。为阐明这种耐药机制,对20株豚鼠气单胞菌(n = 10)、嗜水气单胞菌(n = 5)和温和气单胞菌(n = 5)复合体菌株进行了研究,其中包括3株参考菌株和17株环境分离株。通过聚合酶链反应(PCR)扩增并测序了包含喹诺酮耐药决定区(QRDRs)的gyrA、gyrB、parC和parE基因片段。对6株敏感菌株的研究结果表明,气单胞菌属的GyrA、GyrB、ParC和ParE QRDR片段高度保守(同一性≥96.1%),尽管存在一些基因多态性;它们与弧菌属、假单胞菌属和肠杆菌科成员的片段关系最为密切(同源性为72.4%至97.1%)。所有14株环境耐药菌株在GyrA QRDR的第83位密码子处发生点突变,导致丝氨酸-83被异亮氨酸取代(10株)或丝氨酸-83被精氨酸取代。此外,7株菌株在ParC QRDR的第80位(5株)发生突变,产生丝氨酸-80被异亮氨酸取代(3株)或丝氨酸-80被精氨酸取代的变化,或在第84位发生突变,导致谷氨酸-84被赖氨酸取代。在GyrB和ParE QRDRs中未发现氨基酸改变。与单gyrA突变相比,gyrA-parC双错义突变与更高水平的喹诺酮耐药性相关。耐药性最强的菌株可能还有其他耐药机制,如药物积累减少。我们的数据表明,在嗜温气单胞菌属中,与其他革兰氏阴性菌一样,gyrase和拓扑异构酶IV分别是喹诺酮类药物作用的主要和次要靶点。